Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients

• Published in: Scientific reports Vol. 6; no. 1; p. 31375
• Main Authors: Pérez-Sánchez, C., Aguirre, M. A., Ruiz-Limón, P., Barbarroja, N., Jiménez-Gómez, Y., de la Rosa, I. Arias, Rodriguez-Ariza, A., Collantes-Estévez, E., Segui, P., Velasco, F., Cuadrado, M. J., Teruel, R., González-Conejero, R., Martínez, C., López-Pedrera, Ch
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 09.08.2016; Nature Publishing Group
• Subjects: 13/31; 38/109; 38/61; 692/4023/1670/1613; 692/699/1670/122; 82/1; 82/80; Anti-DNA antibodies; Antibodies; Antiphospholipid syndrome; Arteriosclerosis; Autoantibodies; Autoimmune diseases; Biosynthesis; Humanities and Social Sciences; Immune system; Immunoglobulin G; Leukocytes (neutrophilic); Lupus; MicroRNAs; miRNA; Monocytes; multidisciplinary; Neutrophils; Oxidative stress; Science; Systemic lupus erythematosus; Thromboembolism; Thrombosis
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/srep31375

MicroRNAs markedly affect the immune system and have a relevant role in CVD and autoimmune diseases. Yet, no study has analyzed their involvement in atherothrombosis related to APS and SLE patients. This study intended to: 1) identify and characterize microRNAs linked to CVD in APS and SLE; 2) assess the effects of specific autoantibodies. Six microRNAs, involved in atherothrombosis development, were quantified in purified leukocytes from 23 APS and 64 SLE patients, and 56 healthy donors. Levels of microRNAs in neutrophils were lower in APS and SLE than in healthy donors. Gene and protein expression of miRNA biogenesis-related molecules were also reduced. Accordingly, more than 75% of identified miRNAs by miRNA profiling were underexpressed. In monocytes, miR124a and -125a were low, while miR-146a and miR-155 appeared elevated. Altered microRNAs’ expression was linked to autoimmunity, thrombosis, early atherosclerosis and oxidative stress in both pathologies. In vitro treatment of neutrophils, monocytes and ECs with aPL-IgG or anti-dsDNA-IgG antibodies deregulated microRNAs expression and decreased miRNA biogenesis-related proteins. Monocyte transfections with pre-miR-124a and/or -125a caused reduction in atherothrombosis-related target molecules. In conclusion, microRNA biogenesis, significantly altered in neutrophils of APS and SLE patients, is associated to their atherothrombotic status, further modulated by specific autoantibodies.